Last reviewed · How we verify
NCT03182543
Physiological Effect of Ataulfo Mango (Manguifera Indica) Beverage in Exercise
NA trial testing Mango pulp beverage in Exercise-induced Oxidative Stress in 19 participants. Completed in 30 April 2017.
28 February 2017
Quick facts
| Lead sponsor | Universidad Autonoma de Ciudad Juarez |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 19 |
| Start date | 1 January 2017 |
| Primary completion | 28 February 2017 |
| Estimated completion | 30 April 2017 |
Drugs / interventions tested
- Mango pulp beverage
- Mango pulp and peel beverage
- Control beverage
Conditions studied
- Exercise-induced Oxidative Stress — all drugs for Exercise-induced Oxidative Stress →
Sponsor
Universidad Autonoma de Ciudad Juarez
Who can join
Adults 17 to 28, male only, with Exercise-induced Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess the antioxidant capacity of two mango base beverages (AM1, AM2), against exercise-induced oxidative stress.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03182543
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidad Autonoma de Ciudad Juarez trials
Trials by the same sponsor.
- NCT06123442 — Cognitive Resilience Intervention as a Recovery Therapy for Mental Health · NA · unknown
- NCT02837666 — Hypolipidemic and Antioxidant Capacity of Spirulina and Exercise · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03182543 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Ciudad Juarez
- Last refreshed: 9 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03182543.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing